About Us

Leadership

Thomas B. Broudy, PhD

CEO

20+ years experience growing oncology-focused biotech companies EVP BioDuro-Sundia, GM CrownBio, CSO Molecular Response >100 strategic partnerships: disc & dev PhD, Rockefeller University

Dan Maneval, PhD

Chief Scientific Officer

25+ years experience in oncology, gene therapy, and drug delivery VP Research Halozyme (HALO), Site Head Schering-Plough San Diego Genentech key contributor on Herceptin IND PhD, Biomedical Engineering - University of Southern California

Patrick Kearney, PhD

Head of Early Research and Development

20+ years medicinal chemistry and drug discovery experience – Exelixis, HD Sciences, Deciphera Inventor 20 patent applications PhD, Chemistry - California Institute of Technology

Curt Monnig, PhD

Manufacturing/Scale-up

25+ years experience in pharma/biopharma CMC and manufacturing 25+INDs/10+ NDAs filed Senior roles at Nalproprion, Allergan, Cardinal Health, Amylin Pharmaceuticals PhD, Chemistry - Indiana University at Bloomington

Sam Ellis

Chairman of the Board

20+ Years of Business & Team Building Experience Multiple Life Science Deals VP at Thomson Instrument Company, a successful life science company in San Diego, CA Over 43 patents

Don Rindell

Business Development

30+ year experienced executive - medical device, biotechnology, and pharmaceuticals Recent role - Corporate & Business Development executive, Bristol-Myers Squibb Other executive and business roles at: Amylin Pharmaceuticals, Advanced Tissue Sciences, Braun/Thermoscan

Norm Herman, MS

CMC/Formulation

25+ years in pharmaceutical development and manufacturing. Specializing in solid dosage product development and drug delivery manufacturing Senior roles; Rovan Pharma, Adventrix , Halozyme, Maxim, and Purdue B.S. - Columbia U., M.S. - Industrial Pharmacy, Schwartz College of Pharmacy

Steven Rosen, MD

Chief Medical Advisor

Provost and Chief Scientific Officer of the City of Hope National Medical Center Director City of Hope’s Comprehensive Cancer Center Head Beckman Research Institute at City of Hope, and the Irell & Manella Graduate School of Biological Sciences

Terry Williams, MD PhD

Key Scientific Advisor

Extensive experience in Albumin Metabolic Pathways, solid tumor specialty in Pancreatic, Colorectal, and Lung Professor and Chair Department of Radiation Oncology of the City of Hope National Medical Center MD PhD, Albert Einstein College of Medicine

Scientific Advisors

Bruce Roth, PhD

Inventor of Lipitor. Previously Parke-Davis, Warner-Lambert, Pfizer, Genentech

Miles Miller, PhD

Harvard Medical School and Principal Investigator in the Center for Systems Biology at Massachusetts General Hospital

John Nuss, PhD

Inventor of Cabozantinib, Cobimetinib, and Esazerenone. Previously UC Riverside, Chiron, Exelixis

David Carbone, MD, PhD

Director, James Thoracic Center at Ohio State University

Business Advisors

Mark Simon

Co-Founder of Torreya Partners Previously the Head of Life Sciences Investment Banking at Citigroup, Managing Director at Robinson Stephens

Michael J. Hostetler, Ph.D.

Dr. Hostetler is a Partner with Wilson/Sonsini specializing in patents and innovations, extensively experienced in IP strategy, M&A’s, and corporate financing

David Webb, PhD

Current CEO, Synbal, Inc.; previously Syntex Palo Alto, Roche, OSI, Syrrx, Former Head of Signal Pharmaceutical-Celgene, past Chairman of the Board of BIOCOM

Mark Foletta

Board Member Dexcom, AMN, Enanta, Previously Chief Financial Officer at Tocagen & Amylin Pharmaceuticals